SLGL

Sol-Gel Technologies Ltd. is a pioneering clinical-stage pharmaceutical company specializing in the development and commercialization of innovative topical dermatological products. Utilizing its proprietary microencapsulation delivery system, patented in Israel, Sol-Gel aims to enhance the efficacy and safety of treatments for various skin conditions. Headquartered in Ness Ziona, Israel, the company is committed to addressing significant unmet medical needs in dermatology, positioning itself as a key player in the pharmaceutical landscape.